Page 9 - Published August News Today

Over 3 years, global health threats and national headlines have spurred medical schools to better address social and community-based determinants of health. What comes next?

While the unmet needs of patients of color is a growing concern in the dermatology world, more has to be done to address the obvious disparities in care.

Aside from the clinically significant risks associated with polypharmacy, an increased pill burden can be unaffordable and difficult to manage.

DOMOVOY V. ⸻ Blavatsky sat at her desk facing a large window looking which looked into the green leafy trees of Holland Park. Before her, and all around

Read the latest stories and columns from staff writer S.A. Miller in The Washington Times.

Studies show that patients who had pharmacists as part of their transplant-related care had a significant improvement in clinical outcomes.

From Netflix and YouTube to AMC, CNBC Marathon explores the future of entertainment. Over the past 25 years, Netflix revolutionized the film and television industry. The company amassed over 220 million subscribers across 190 countries, billions of hours watched for show Stranger Things and racked in 226 award wins. However, in 2022, things began looking rather different for the storied streamer while fighting an uphill battle to remain relevant in the streaming wars. In Q2 of 2022, Netflix lost...

A prespecified analysis of the DELIVER trial provides insight into the effects of dapagliflozin use on total heart failure events in patients with mildly reduced or preserved ejection fraction.

This feature articles commemorates the 10-year anniversary of the FDA's first approval of an SGLT2 inhibitor on March 29, 2013 and provides a snapshot at the class's ascent into the treatment algorithms and guidelines for type 2 diabetes, heart failure, and chronic kidney disease.

A silent disease characterized as a chronic cutaneous neuropathy, notalgia paresthetica has an unmet need yet to be fully understood and, dermatologists argue, an FDA-approved treatment could help improve understanding of the etiology and prevalence of this disease.